About the webinar
Organizations are inundated with obesity solutions, and uncovering the actual clinical impact of an individual solution can be difficult. How can organizations know what to look for when evaluating solutions?
Dr. Louise Short, National Clinical Leader at Brown & Brown, and Gretchen Zimmermann, VP of Clinical Strategy at Vida, dive into the science and outline what organizations need to weigh when making their decisions.
Watch the replay to learn:
- How to determine if your organization needs a solution that can prescribe, only offers behavior change, or provides a combined approach
- How different types of solutions manage access to anti-obesity medications
- If solutions can reduce the total cost of care — and what guarantees they can (and should) offer
Featured speakers
Gretchen Zimmermann
VP of Clinical Strategy
at Vida
Dr. Louise Short, MD, MSc
Brown & Brown Insurance
Dominic Belmonte
Senior Manager of Partnerships at Vida
Curious to read more?
FAQs about Obesity Step Therapy answers your questions on obesity step therapy and behavior change with managed access to prescriptions make for the best outcomes.